Bone Disease after Kidney Transplantation

Seminars in Nephrology

Volumn 24, Issue 1, 2004, Pages 82-90

  Sprague, Stuart M ^a   Josephson, Michelle A ^b  

^a NORTHWESTERN UNIVERSITY   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCINEURIN INHIBITOR; GLUCOCORTICOID; IMMUNOSUPPRESSIVE AGENT; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; BONE BIOPSY; BONE DISEASE; BONE METABOLISM; DIABETES MELLITUS; FEMALE; FRACTURE; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; MALE; MINERAL METABOLISM; OSSIFICATION; OSTEOLYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SURGICAL RISK;

EID: 0942301267     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.semnephrol.2003.08.012     Document Type: Article

References (102)

1. Stehman-Breen CO, Sherrard DJ, Alem AM, et al: Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int 58:2200-2205, 2000
2. Alem AM, Sherrard DJ, Gillen DL, et al: Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int 58:396-399, 2000
3. Ball AM, Gillen DL, Sherrard D, et al: Risk of hip fracture among dialysis and renal transplant recipients. JAMA 288:3014-3018, 2002
4. Elmstedt E, Svahn T: Skeletal complications following renal transplantation. Acta Orthop Scand 52:279-286, 1981
5. Davidson JK, Tsakiris D, Briggs JD, et al: Osteonecrosis and fractures following renal transplantation. Clin Radiol 36:27-35, 1985
6. Ramsey-Goldman RR, Dunn JE, Dunlop DD, et al: Increased risk of fracture in patients receiving solid organ transplants. J Bone Miner Res 14:456-463, 1999
7. Arlen DJ, Lambert K, Ioannidis G, et al: Treatment of established bone loss after renal transplantation with etidronate. Transplantation 71:669-673, 2001
8. O'Shaughnessy EA, Dahl DC, Smith CL, et al: Risk factors for fractures in kidney transplantation. Transplantation 74:362-366, 2002
9. Durieux S, Mercadal L, Orcel P, et al: Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 74:496-500, 2002
10. Grotz WH, Mundinger FA, Gugel B, et al: Bone fracture and osteodensitometry with dual energy x-ray absorptiometry in kidney transplant recipients. Transplantation 58:912-915, 1994
11. Parker CR, Freemont AJ, Blackwell PJ, et al: Cross-sectional analysis of renal transplantation osteoporosis. J Bone Miner Res 14:1943-1951, 1999
12. Patel S, Kwan JTC, McCloskey E, et al: Prevalence and causes of low bone density and fractures in kidney transplant patients. J Bone Miner Res 16:1863-1870, 2001
13. D'Angelo A, Calo L, Giannini S, et al: Parathyroid hormone and bone metabolism in kidney-transplanted patients. Clin Nephrol 53:19-22, 2000
14. Nam JH, Moon JI, Chung SS, et al: Prevalence and risk factors for vertebral fractures in renal transplants. Transplant Proc 32:1877, 2000
15. Chiu MY, Sprague SM, Bruce DS, et al: Analysis of fracture prevalence in kidney-pancreas allograft recipients. J Am Soc Nephrol 9:677-683, 1998
16. Nisbeth U, Lindh E, Ljunghall S, et al: Increased fracture rate in diabetes mellitus and females after renal transplantation. Transplantation 67:1218-1222, 1999
17. Abbott KC, Oglesby RJ, Hypolite IO, et al: Hospitalizations for fractures after renal transplantation in the United States. Ann Epidemiol 11:450-457, 2001
18. Kwan JT, Almond MK, Evans K, et al: Changes in total body bone mineral content and regional bone mineral density in renal patients following renal transplantation. Miner Electrolyte Metab 18:166-168, 1992
19. Feber J, Cochat P, Braillon P, et al: Bone mineral density after renal transplantation in children. J Pediatr 6:870-875, 1994
20. McIntyre HD, Menzies B, Rigby R, et al: Long-term bone loss after renal transplantation: Comparison of immunosuppressive regimens. Clin Transplant 9:20-24, 1995
21. Torres A, Machado M, Concepcion MT, et al: Influence of vitamin D receptor genotype on bone mass changes after renal transplantation. Kidney Int 50:1726-1733, 1996
22. Yun YS, Kim BJ, Hong SP, et al: Changes of bone metabolism indices in patients receiving immunosuppressive therapy including low doses of steroids after renal transplantation. Transplant Proc 28:1561-1564, 1996
23. Kim MS, Kim YS, Lim SK, et al: Effect of deflazacort on bone mineral density in renal transplant recipients. Transplant Proc 30:3041-3042, 1998
24. Lippuner K, Casez J-P, Horber FF, et al: Effects of deflazacort versus prednisone on bone mass, body composition and lipid profile: A randomized double blind study in kidney transplant patients. J Clin Endocrinol Metab 83:3795-3802, 1998
25. Smets YFC, van der Pijl JW, Ringers J, et al: Pattern of bone loss after simultaneous pancreas-kidney transplantation: A prospective study. Transplant Proc 30:326, 1998
26. Isiklar I, Akin O, Demirag A, et al: Changes in bone mineral density after renal transplantation. Transplant Proc 30:814-185, 1998
27. Moreno A, Torregrosa JV, Pons F, et al: Bone mineral density after renal transplantation. Transplant Proc 31:2322-2323, 1999
28. Fan SLS, Almond MK, Ball E, et al: Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 57:684-690, 2000
29. Nam J-H, Moon JI, Chung S-S, Kim S-I, et al: Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation. Transplant Proc 32:1876, 2000
30. Kokado Y, Takahara S, Ichimaru N, et al: Factors influencing vertebral bone density after renal transplantation. Transpl Int 13:S431-S435, 2000
31. Goffin E, Devogelaer J-P, Lalaoui A, et al: Tacrolimus and low-dose steroid immunosuppression preserves bone mass after renal transplantation. Transpl Int 15:73-80, 2002
32. Julian BA, Laskow DA, Dubovsky J, et al: Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325:544-550, 1991
33. Horber FF, Casez JP, Steiger U, et al: Changes in bone mass early after kidney transplantation. J Bone Miner Res 9:1-9, 1994
34. Almond MK, Kwan JT, Evans K, et al: Loss of regional bone mineral density in the first 12 months following renal transplantation. Nephron 66:52-57, 1994
35. Grotz W, Nagel C, Poeschel D, et al: Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 12:1530-1537, 2001
36. Grotz WH, Mundinger FA, Gugel B, et al: Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation. Transplantation 59:982-986, 1995
37. Ugur A, Guvener N, Isiklar I, et al: Osteoporosis after renal transplantation: Single center experience. Transplantation 71:645-649, 2001
38. Nowacka-Cieciura E, Durlik M, Cieciura T, et al: Steroid withdrawal after renal transplantation-risks and benefits. Transplant Proc 34:560-563, 2002
39. Aroldi A, Tarantino A, Montagnino G, et al: Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: A prospective study. Transplantation 63:380-386, 1997
40. Bagni B, Gilli P, Cavallini A, et al: Continuing loss of vertebral mineral density in renal transplant recipients. Eur J Nucl Med 21:108-112, 1994
41. Hurst G, Alloway R, Hathaway D, et al: Stabilization of bone mass after renal transplant with preemptive care. Transplant Proc 30:1327-1328, 1998
42. Yazawa K, Ishikawa T, Ichikawa Y, et al: Positive effects of kidney transplantation on bone mass. Transplant Proc 30:3031-3033, 1998
43. Kim H, Chang K, Lee T, et al: Bone mineral density after renal transplantation. Transplant Proc 30:3029-3030, 1998
44. Cueto-Manzano AM, Konel S, Freemont AJ, et al: Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. Am J Kidney Dis 35:227-236, 2000
45. Grotz WH, Rump LC, Niessen A, et al: Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation 66:1004-1008, 1998
46. Cruz D, Wysolmerski JJ, Brickel H, et al: Parameters of high bone-turnover predict bone loss in renal transplant patients: A longitudinal study. Transplantation 72:83-88, 2001
47. Brandenburg VM, Ketteler M, Fassbender WJ, et al: Development of lumbar bone mineral density in the late course after kidney transplantation. Am J Kidney Dis 40:1066-1074, 2002
48. Smets YF, van der Pilj JW, de Fijter JW, et al: Low bone mass and high incidence of fractures after successful simultaneous pancreas-kidney transplantation. Nephrol Dial Transplant 13:1250-1255, 1998
49. Velasquez-Forero F, Mondragon A, Herrero B, et al: Adynamic bone lesion in renal transplant recipients with normal renal function. Nephrol Dial Transplant 11:58-64, 1996 (suppl 3)
50. Braun WE, Richmond BJ, Protiva DA, et al: The incidence and management of osteoporosis, gout, and avascular necrosis in recipients of renal allografts functioning more than 20 years (level 5A) treated with prednisone and azathioprine. Transplant Proc 31:1366-1369, 1999
51. Carlini RG, Rojas E, Weisinger JR, et al: Bone disease in patients with long-term renal transplantation and normal renal function. Am J Kidney Dis 36:160-166, 2000
52. Heaf J, Tvedgaard E, Kanstrup I-L, et al: Bone loss after renal transplantation: Role of hyperparathyroidism, acidosis, cyclosporine and systemic disease. Clin Transplant 14:457-463, 2000
53. Ellis EN, Floyd-Gimon DM, Berry PL, et al: Risk factors for bone mineral density loss in pediatric renal transplant patients. Pediatr Transplant 4:146-150, 2000
54. Cayco AV, Wysolmerski J, Simpson C, et al: Posttransplant bone disease: Evidence for a high bone resorption state. Transplantation 70:1722-1728, 2000
55. Kovac D, Lindic J, Kandus A, et al: Bone mineral density in kidney transplant recipients. Transplant Proc 33:3668-3669, 2001
56. Pichette V, Bonnardeaux A, Prudhomme L, et al: Long-term bone loss in kidney transplant recipients: A cross-sectional and longitudinal study. Am J Kidney Dis 28:105-114, 1996
57. Wolpaw T, Deal CL, Fleming-Brooks S, et al: Factors influencing vertebral bone density after renal transplantation. Transplantation 58:1186-1189, 1994
58. Boiskin I, Epstein S, Ismail F, et al: Serum osteocalcin and bone mineral metabolism following successful renal transplantation. Clin Nephrol 31:316-322, 1989
59. Schmidt H, Stracke H, Schatz H, et al: Osteocalcin serum levels in patients following renal transplantation. Klin Wochenschr 67:297-303, 1989
60. Saha HH, Salmela KT, Ahonen PJ, et al: Sequential changes in vitamin D and calcium metabolism after successful renal transplantation. Scand J Urol Nephrol 28:21-27, 1994
61. Withold W, Degenhardt S, Heins M, et al: Monitoring of bone resorption after renal transplantation by measuring the urinary excretion of pyridinium cross-links. Eur J Clin Chem Clin Biochem 33:15-21, 1995
62. Bonnin MR, Gonzalez MT, Grino JM, et al: Changes in serum osteocalcin levels in the follow-up of kidney transplantation. Ann Clin Biochem 34:651-655, 1997
63. Barbarykin D, Adamsone I, Amerika D, et al: Disorders of calcium metabolism at various times after renal transplantation. Ann Transplant 4:46-53, 1999
64. Kusec V, Smalcelj R, Cvijetic S, et al: Determinants of reduced bone mineral density and increased bone turnover after kidney transplantation: Cross-sectional study. Croat Med J 41:396-400, 2000
65. Westeel FP, Mazouz H, Ezaitouni F, et al: Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation. Kidney Int 58:1788-1796, 2000
66. Cundy T, Kanis JA: Rapid suppression of plasma alkaline phosphatase activity after renal transplantation in patients with osteodystrophy. Clin Chim Acta 164:285-291, 1987
67. van Straalen JP, Sanders E, Prummel MF, et al: Bone-alkaline phosphatase as indicator of bone formation. Clin Chim Acta 201:27-33, 1991
68. Withold W, Friedrich W, Degenhardt S: Serum bone alkaline phosphatase is superior to plasma levels of bone matrix proteins for assessment of bone metabolism in patients receiving renal transplants. Clin Chim Acta 261:105-115, 1997
69. Withold W, Degenhardt S, Grabensee B, et al: Comparison between serum levels of bone alkaline phosphatase and the carboxy-terminal propeptide of type I procollagen as markers of bone formation in patients following renal transplantation. Clin Chim Acta 239:143-151, 1995
70. Epstein S, Traberg H, Raja R, et al: Serum and dialysate osteocalcin levels in hemodialysis and peritoneal dialysis patients and after renal transplantation. J Clin Endocrinol Metab 60:1253-1256, 1985
71. Reusz GS, Szabo AJ, Peter F, et al: Bone metabolism and mineral density following renal transplantation. Arch Dis Child 83:146-151, 2000
72. Pietschmann P, Vychytil A, Woloszczuk W, Kovarik J: Bone metabolism in patients with functioning kidney grafts: Increased serum levels of osteocalcin and parathyroid hormone despite normalisation of kidney function. Nephron 59:533-536, 1991
73. Amado JA, Riancho JA, De Francisco AL, et al: Hyperparathyroidism is responsible for the increased levels of osteocalcin in patients with normally functioning kidney grafts. Nephron 52:209-215, 1989
74. Dumoulin G, Hory B, Nguyen NU, et al: No trend toward a spontaneous improvement of hyperparathyroidism and high bone turnover in normocalcemic long-term renal transplant recipients. Am J Kidney Dis 29:746-753, 1997
75. Giannini S, D'Angelo A, Carraro G, et al: Persistently increased bone turnover and low bone density in long-term survivors to kidney transplantation. Clin Nephrol 56:353-363. 2001
76. Briner VA, Thiel G, Monier-Faugere MC, et al: Prevention of cancellous bone loss but persistence of renal bone disease despite normal 1,25 vitamin D levels two years after kidney transplantation. Transplantation 59:1393-1400. 1995
77. Carlini RG, Rojas E, Arminio A, et al: What are the bone lesions in patients with more than four years of a functioning renal transplant? Nephrol Dial Transplant 13:103-104, 1998 (suppl 3)
78. Cueto-Manzano AM, Konel S, Hutchison AJ, et al: Bone loss in long-term renal transplantation: Histopathology and densitometry analysis. Kidney Int 55:2021-2029, 1999
79. Sanchez CP, Salusky IB, Kuizon BD, et al: Bone disease in children and adolescents undergoing successful renal transplantation. Kidney Int 53:1358-1364, 1998
80. Weisinger JR, Carlini RG, Rojas E, et al: Bone disease after renal transplantation. Transplant Proc 31:3033-3034, 1999
81. Monier-Faugere MC, Mawad H, Qi Q, et al: High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol 11:1093-1099, 2000
82. Parker CR, Blackwell PJ, Freemont AJ, et al: Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women. Am J Kidney Dis 40:385-396, 2002
83. Rubin MR, Bilezikian JP: Clinical review 151: The role of parathyroid hormone in the pathogenesis of glucocorticoid-induced osteoporosis: A re-examination of the evidence. J Clin Endocrinol Metab 87:4033-4041, 2002
84. Epstein S: Post-transplantation bone disease: The role of immunosuppressive agents and the skeleton. J Bone Miner Res 11:1-7, 1996
85. Stewart PJ, Stern PH: Cyclosporines: Correlation of immunosuppressive activity and inhibition of bone resorption. Calcif Tissue Int 45:222-226, 1989
86. Stewart PJ, Stern PH: Interaction of cyclosporine A and calcitonin on bone resorption in vitro. Horm Metab Res 21:194-197, 1989
87. Bowman AR, Sass DA, Dissanayake IR, et al: The role of testosterone in cyclosporine-induced osteopenia. J Bone Miner Res 12:607-615, 1997
88. Epstein S, Dissanayake IR, Goodman GR, et al: Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat. Calcif Tissue Int 68:240-247, 2001
89. Awumey EM, Moonga BS, Sodam BR, et al: Molecular and functional evidence for calcineurin-A alpha and beta isoforms in the osteoclast: novel insights into cyclosporin A action on bone resorption. Biochem Biophys Res Commun 254:248-252, 1999
90. Buchinsky FJ, Ma Y, Mann GN, et al: T lymphocytes play a critical role in the development of cyclosporin A-induced osteopenia. Endocrinology 137:2278-2285, 1996
91. Ponticelli C, Aroldi A: Osteoporosis after organ transplantation. Lancet 357:1623, 2001
92. Grotz W, Mundinger A, Gugel B, et al: Missing impact of cyclosporine on osteoporosis in renal transplant recipients. Transplant Proc 26:2652-2653, 1994
93. Monegal A, Navasa M, Guanabens N, et al: Bone mass and mineral metabolism in liver transplant patients treated with FK506 or cyclosporine A. Calcif Tissue Int 68:83-86, 2001
94. Sambrook P: Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation. Calcif Tissue Int 65:341-343, 1999
95. Lippuner K, Haller B, Casez JP, et al: Effect of disodium monofluorophosphate, calcium and vitamin D supplementation on bone mineral density in patients chronically treated with glucocorticosteroids: A prospective, randomized, double-blind study. Miner Electrolyte Metab 22:207-213, 1996
96. Meys E, Terreaux-Duvert F, Beaume-Six T, et al: Bone loss after cardiac transplantation: Effects of calcium, calcidiol and monofluorophosphate. Osteoporos Int 3:322-329, 1993
97. Garcia-Delgado I, Prieto S, Gil-Fraguas L, et al: Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int 60:155-159, 1997
98. Josephson MA, Schumm LP, Chiu MY, et al: Calcium and calcitriol prophylaxis against post-transplant bone loss. J Am Soc Nephrol 11:720A, 2000 (abstr)
99. Giannini S, D'Angelo A, Carraro G, et al: Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res 16:2111-2117, 2001
100. Kovac D, Lindic J, Kandus A, et al: Prevention of bone loss in kidney graft recipients. Transplant Proc 33:1144-1145, 2001
101. Haas M, Leko-Mohr Z, Roschger P, et al: Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation. Kidney Int 63:1130-1136, 2003
102. Markowitz GS, Appel GB, Fine PL, et al: Collapsing focal segmental glomerulosclerosis following treatment with high-dose pamidronate. J Am Soc Nephrol 12:1164-1172, 2001